BioCentury
ARTICLE | Company News

Syntro, Mallinckrodt Group Inc. deal

October 2, 1995 7:00 AM UTC

The Mallinckrodt Veterinary Acquisitions Inc. subsidiary on Friday began a cash tender offer, which will expire on Oct. 27, for SYNT's 11.5 million shares outstanding at $3.55 per share. The boards of both companies have approved the merger, under which SYNT will become a wholly owned subsidiary of the St. Louis company. SYNT shares closed at $3.375 on Friday. ...